157 related articles for article (PubMed ID: 30721793)
1. Clinicopathological significance of tumor cyclin D1 expression in oral cancer.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Bravo M; Gil-Montoya JA
Arch Oral Biol; 2019 Mar; 99():177-182. PubMed ID: 30721793
[TBL] [Abstract][Full Text] [Related]
2. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Lenouvel D; Gil-Montoya JA; Bravo M
Arch Oral Biol; 2019 Jan; 97():12-17. PubMed ID: 30321764
[TBL] [Abstract][Full Text] [Related]
4. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
Nazar M; Naz I; Mahmood MK; Hashmi SN
Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
[TBL] [Abstract][Full Text] [Related]
9. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Cyclins A2, B1, D1, and E1 and
Monteiro LS; Diniz-Freitas M; Warnakulasuriya S; Garcia-Caballero T; Forteza-Vila J; Fraga M
Anal Cell Pathol (Amst); 2018; 2018():7253510. PubMed ID: 29785357
[TBL] [Abstract][Full Text] [Related]
11. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
15. Comparison between immunohistochemical expression of cyclin D1 and p21 and histological malignancy graduation of oral squamous cell carcinomas.
Neves Ada C; Mesquita RA; Novelli MD; Toddai E; De Sousa SO
Braz Dent J; 2004; 15(2):93-8. PubMed ID: 15776189
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomas.
Olimid DA; Simionescu CE; Mărgăritescu C; Florescu A
Rom J Morphol Embryol; 2012; 53(3 Suppl):795-8. PubMed ID: 23188442
[TBL] [Abstract][Full Text] [Related]
18. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
19. Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
Saawarn S; Astekar M; Saawarn N; Dhakar N; Gomateshwar Sagari S
ScientificWorldJournal; 2012; 2012():978327. PubMed ID: 22629227
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]